Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

      Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

      Medical Dialogues Bureau21 Jan 2020 10:00 AM IST
      "We are looking at a revenue of over Rs 1,000 crore for the fiscal year 2022. It will be achieved through organic and inorganic growth," Trivitron...
      Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

      Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

      Medical Dialogues Bureau20 Jan 2020 12:00 PM IST
      Kiran Mazumdar Shaw, Biocon founder and an Australian Global Alumni Ambassador, is also recognised for her sustained and significant contribution to...
      Lupin gets 5 USFDA observations for Vizag facility

      Lupin gets 5 USFDA observations for Vizag facility

      Medical Dialogues Bureau20 Jan 2020 11:24 AM IST
      The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
      NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

      NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

      Medical Dialogues Bureau20 Jan 2020 11:02 AM IST
      New Delhi: The Narcotics Control Bureau(NCB) has unearthed an inter-state racket of psychotropic medicine traffickers with the seizure of over 7 lakh...
      Drugmajors slash prices by 53pc for China bulk-buy program eligibility

      Drugmajors slash prices by 53pc for China bulk-buy program eligibility

      Medical Dialogues Bureau20 Jan 2020 10:00 AM IST
      Beijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
      ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

      ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

      Medical Dialogues Bureau20 Jan 2020 9:45 AM IST
      New Delhi: ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava's novel...
      Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™  for Dry Eye Disease

      Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™ for Dry Eye Disease

      Medical Dialogues Bureau19 Jan 2020 10:45 AM IST
      Watertown: Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...
      JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

      JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

      Medical Dialogues Bureau19 Jan 2020 10:00 AM IST
      Mumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
      CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

      CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

      Medical Dialogues Bureau19 Jan 2020 9:45 AM IST
      Oakville: UCB Canada Inc. announced that Health Canada has approved CIMZIA® (certolizumab pegol) for the treatment of adults with severe active...
      German drug assessment body not convinced by Bayers cancer drug Vitrakvi

      German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

      Medical Dialogues Bureau19 Jan 2020 9:30 AM IST
      Frankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence...
      Piramal Divests its Healthcare analytics Business for 950 Million USD

      Piramal Divests its Healthcare analytics Business for 950 Million USD

      Medical Dialogues Bureau18 Jan 2020 3:30 PM IST
      India: Piramal Enterprises Limited has announced that PEL DRG Dutch HoldCo BV, a 100% subsidiary of PEL and the holding company for Decision Resources...
      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Medical Dialogues Bureau18 Jan 2020 12:17 PM IST
      New York: A Pennsylvania court on Friday slashed a USD 8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok